InMode Ltd. (INMD)Healthcare | Medical Devices | Yokne'am, Israel | NasdaqGS
14.28 USD
-0.03
(-0.175%) ⇩
(Oct. 14, 2026, 4 p.m.
EDT)
|
Hot Take ↕ | Oct. 10, 2026, 11:34 a.m. EDT
The investment case here is severely compromised by a brutal multi-year price trajectory. Despite the company reporting a 5% revenue increase and beating EPS estimates recently, the stock has suffered four consecutive years of negative annual returns, culminating in a massive collapse from its 2021 highs. The market is clearly pricing in a structural deterioration of the business, evidenced by the heavy put option positioning and the lack of speculative call interest. While the valuation metrics look attractive on paper—trading at a low P/E and P/B—the persistent decline suggests these multiples reflect a broken growth story rather than a margin of safety. With no dividend to provide income and a statistical forecast showing a weak bearish lean, the risk-reward profile remains skewed against the buyer until the multi-year downtrend shows definitive signs of reversal. |
| Model | MAE |
|---|---|
| AutoTheta ✓ | 0.036117 |
| AutoETS | 0.039455 |
| AutoARIMA | 0.039499 |
| MSTL | 0.045319 |
Forecast horizon: 45 days | Selected: AutoTheta
| Forecast Reliability | |
|---|---|
| Score | 43% |
| H-stat | 11.94 |
| Ljung-Box p | 0.000 |
| Jarque-Bera p | 0.062 |
| Excess Kurtosis | -0.39 |
| Attribute | Value |
|---|---|
| Sector | Healthcare |
| Debt to Equity Ratio | 0.707 |
| Revenue per Share | 6.022 |
| Market Cap | 821,730,752 |
| Trailing P/E | 11.80 |
| Forward P/E | 10.41 |
| Beta | 2.03 |
| Profit Margins | 20.69% |
| Website | https://www.inmodemd.com |
As of Oct. 10, 2026, 11:34 a.m. EDT: Speculators are heavily positioned for downside protection, with out-of-the-money put open interest significantly outweighing call open interest across nearly all expirations. The 'top OI' strikes for puts are clustered deep in the money (e.g., $13.00), while call interest is concentrated at lower strikes ($15.00-$16.00) with minimal volume at higher targets. This distribution suggests a market consensus expecting further price weakness rather than a rally.
| Attribute | Value |
|---|---|
| 52 Week Change | -0.064832985 |
| Address1 | Tavor Building |
| Address2 | Sha’ar Yokneam PO Box 533 |
| All Time High | 99.27 |
| All Time Low | 6.53 |
| Ask | 18.3 |
| Ask Size | 2 |
| Average Analyst Rating | 3.0 - Hold |
| Average Daily Volume10 Day | 458,130 |
| Average Daily Volume3 Month | 484,006 |
| Average Volume | 484,006 |
| Average Volume10Days | 458,130 |
| Beta | 2.028 |
| Bid | 10.23 |
| Bid Size | 2 |
| Book Value | 10.681 |
| City | Yokne'am |
| Compensation As Of Epoch Date | 1,767,139,200 |
| Country | Israel |
| Crypto Tradeable | 0 |
| Currency | USD |
| Current Price | 14.28 |
| Current Ratio | 8.183 |
| Custom Price Alert Confidence | HIGH |
| Date Short Interest | 1,790,726,400 |
| Day High | 14.295 |
| Day Low | 14.21 |
| Debt To Equity | 0.707 |
| Display Name | InMode |
| Dividend Yield | 0.0 |
| Earnings Call Timestamp End | 1,778,070,600 |
| Earnings Call Timestamp Start | 1,778,070,600 |
| Earnings Growth | -0.31 |
| Earnings Quarterly Growth | -0.362 |
| Earnings Timestamp | 1,794,400,200 |
| Earnings Timestamp End | 1,794,400,200 |
| Earnings Timestamp Start | 1,794,400,200 |
| Ebitda | 71,147,000 |
| Ebitda Margins | 0.18992001 |
| Enterprise To Ebitda | 4.842 |
| Enterprise To Revenue | 0.92 |
| Enterprise Value | 344,470,848 |
| Eps Current Year | 1.296 |
| Eps Forward | 1.372 |
| Eps Trailing Twelve Months | 1.21 |
| Esg Populated | 0 |
| Exchange | NMS |
| Exchange Data Delayed By | 15 |
| Exchange Timezone Name | America/New_York |
| Exchange Timezone Short Name | EDT |
| Fifty Day Average | 14.683 |
| Fifty Day Average Change | -0.40299988 |
| Fifty Day Average Change Percent | -0.0274467 |
| Fifty Two Week Change Percent | -6.4832983 |
| Fifty Two Week High | 16.67 |
| Fifty Two Week High Change | -2.3900003 |
| Fifty Two Week High Change Percent | -0.14337134 |
| Fifty Two Week Low | 12.72 |
| Fifty Two Week Low Change | 1.5599995 |
| Fifty Two Week Low Change Percent | 0.12264147 |
| Fifty Two Week Range | 12.72 - 16.67 |
| Financial Currency | USD |
| First Trade Date Milliseconds | 1,565,271,000,000 |
| Float Shares | 49,122,157 |
| Forward Eps | 1.372 |
| Forward P E | 10.408163 |
| Free Cashflow | 47,395,376 |
| Full Exchange Name | NasdaqGS |
| Full Time Employees | 660 |
| Fullday Change | -0.07999992 |
| Fullday Change Percent | -0.5602236 |
| Fullday Price | 14.2 |
| Gmt Off Set Milliseconds | -14,400,000 |
| Gross Margins | 0.76524 |
| Gross Profits | 286,676,992 |
| Has Pre Post Market Data | 1 |
| Held Percent Insiders | 0.13161999 |
| Held Percent Institutions | 0.55945 |
| Implied Shares Outstanding | 57,544,172 |
| Industry | Medical Devices |
| Industry Disp | Medical Devices |
| Industry Key | medical-devices |
| Is Earnings Date Estimate | 0 |
| Language | en-US |
| Last Fiscal Year End | 1,767,139,200 |
| Last Split Date | 1,633,046,400 |
| Last Split Factor | 2:1 |
| Long Business Summary | InMode Ltd. designs, develops, manufactures, and markets minimally invasive aesthetic medical products based on its proprietary radio frequency assisted lipolysis and deep subdermal fractional radiofrequency technologies in the United States, Europe, Asia, and internationally. It offers minimally invasive aesthetic medical products for various procedures, such as liposuction with simultaneous skin tightening, body and face contouring, and ablative skin rejuvenation treatments, as well as for use in women's health conditions and procedures. The company also designs, develops, manufactures, and markets non-invasive medical aesthetic products that target an array of procedures, including permanent hair reduction, facial skin rejuvenation, wrinkle reduction, cellulite treatment, skin appearance and texture, and superficial benign vascular and pigmented lesions. In addition, it offers hands-free medical aesthetic products that target a range of procedures, such as skin tightening, fat reduction, and muscle stimulation. The company sells and markets its products in the United States, Canada, the United Kingdom, Ireland, Spain, Portugal, France, Belgium, Luxemburg, Italy, Germany, Austria, Japan, Australia, and India through distributors. The company was formerly known as Invasix Ltd. and changed its name to InMode Ltd. in November 2017. The company was incorporated in 2008 and is headquartered in Yokne'am, Israel. |
| Long Name | InMode Ltd. |
| Market | us_market |
| Market Cap | 821,730,752 |
| Market State | PRE |
| Max Age | 86,400 |
| Message Board Id | finmb_100060854 |
| Most Recent Quarter | 1,782,777,600 |
| Net Income To Common | 77,514,000 |
| Next Fiscal Year End | 1,798,675,200 |
| Non Diluted Market Cap | 816,551,800 |
| Number Of Analyst Opinions | 3 |
| Open | 14.27 |
| Operating Cashflow | 83,578,000 |
| Operating Margins | 0.12823 |
| Payout Ratio | 0.0 |
| Peg Ratio | 0.83 |
| Phone | 972 4 909 6313 |
| Pre Market Change | -0.07999992 |
| Pre Market Change Percent | -0.5602236 |
| Pre Market Price | 14.2 |
| Pre Market Time | 1,792,051,208 |
| Previous Close | 14.305 |
| Price Eps Current Year | 11.018518 |
| Price Hint | 2 |
| Price To Book | 1.3369535 |
| Price To Sales Trailing12 Months | 2.1934755 |
| Profit Margins | 0.20691 |
| Quick Ratio | 6.869 |
| Quote Source Name | Nasdaq Real Time Price |
| Quote Type | EQUITY |
| Recommendation Key | hold |
| Recommendation Mean | 3.0 |
| Region | US |
| Regular Market Change | -0.0250006 |
| Regular Market Change Percent | -0.174768 |
| Regular Market Day High | 14.295 |
| Regular Market Day Low | 14.21 |
| Regular Market Day Range | 14.21 - 14.295 |
| Regular Market Open | 14.27 |
| Regular Market Previous Close | 14.305 |
| Regular Market Price | 14.28 |
| Regular Market Time | 1,792,008,001 |
| Regular Market Volume | 337,645 |
| Return On Assets | 0.06165 |
| Return On Equity | 0.12328 |
| Revenue Growth | -0.0 |
| Revenue Per Share | 6.022 |
| Sand P52 Week Change | 0.1570785 |
| Sector | Healthcare |
| Sector Disp | Healthcare |
| Sector Key | healthcare |
| Shares Outstanding | 57,544,172 |
| Shares Percent Shares Out | 0.0392 |
| Shares Short | 2,253,383 |
| Shares Short Previous Month Date | 1,788,134,400 |
| Shares Short Prior Month | 2,348,306 |
| Short Name | InMode Ltd. |
| Short Percent Of Float | 0.0444 |
| Short Ratio | 4.41 |
| Source Interval | 15 |
| Symbol | INMD |
| Target High Price | 17.0 |
| Target Low Price | 15.0 |
| Target Mean Price | 16.16667 |
| Target Median Price | 16.5 |
| Total Cash | 501,115,008 |
| Total Cash Per Share | 8.507 |
| Total Debt | 4,451,000 |
| Total Revenue | 374,624,992 |
| Tradeable | 0 |
| Trailing Annual Dividend Rate | 0.0 |
| Trailing Annual Dividend Yield | 0.0 |
| Trailing Eps | 1.21 |
| Trailing P E | 11.801652 |
| Trailing Peg Ratio | None |
| Triggerable | 1 |
| Two Hundred Day Average | 14.381525 |
| Two Hundred Day Average Change | -0.10152531 |
| Two Hundred Day Average Change Percent | -0.0070594256 |
| Type Disp | Equity |
| Volume | 337,645 |
| Website | https://www.inmodemd.com |
| Zip | 2,069,206 |